In the News | Friends of Cancer Research

You are here

In the News

June 5, 2019
Restrictive eligibility criteria may limit or even jeopardize data generalizability of the trial results and opportunities for patients to participate in a clinical trial. [1][2]   And while the... Read more
June 5, 2019
The use of expanded eligibility criteria would allow nearly twice as many people with non-small cell lung cancer to participate in clinical trials, according to data presented at ASCO Annual Meeting... Read more
June 4, 2019
The Food and Drug Administration (FDA) revealed its pilot program, designed to assist oncologists and patients requesting access to unapproved therapies in the cancer space.   The two-pronged program... Read more
June 4, 2019
The results of a study led by physicians at Fred Hutchinson Cancer Research Center showed that patients living with HIV and one of a variety of potentially deadly cancers could be safely treated with... Read more
June 4, 2019
People with advanced colorectal cancer that has spread to the liver can undergo laparoscopic surgery instead of open surgery without affecting their chances of survival, according to data presented... Read more
June 4, 2019
People living with HIV can safely use checkpoint inhibitors, a type of immunotherapy that unleashes T-cell activity against cancer, according to study results presented at the American Society of... Read more
June 3, 2019
A broader set of clinical trial eligibility criteria proposed by the American Society of Clinical Oncology (ASCO) and Friends of Cancer Research would nearly double the number of patients with... Read more
June 3, 2019
A study that examined 10,500 health records of patients with advanced non–small cell lung cancer from ASCO’s CancerLinQ database found that the use of expanded clinical trial inclusion criteria—as... Read more
June 3, 2019
The FDA has unveiled what it describes as a pilot “concierge service” for oncologists and patients seeking information and assistance with expanded access (EA) to investigational therapies. The two-... Read more
June 3, 2019
The FDA says it is making it easier for doctors to access unapproved therapies for cancer patients, but Richard Padzur, MD, is emphatic: the pilot program, called Project Facilitate, only covers... Read more

Pages